E
COMPANY PROFILE
Epizyme
Epizyme - Personalized Therapeutics & The Power of Epigenetics
At a glance
- Status
- Listed
- Listing
- IPO 2013
News
Open roles
Looking for a job? The startup jobs board lists open roles.Startups hiring now →
Epizyme in the Cambridge ecosystem
The Epizyme office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Loading the map…
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- MBMPM BioImpact
- TSThe Leukemia & Lymphoma Society
- GSGSK
Kleiner Perkins
Series B and later5 investors entered at this stage
- RPRoyalty Pharma
- BMBaylor College of Medicine
- AVAmgen Ventures
- BCBay City Capital
NEA
Founders
Hidden — book a demo/100
quality score
Key operators
Hidden — book a demo
quality score
Potential founders
Hidden — book a demo
likely future founders
Talent movements
Hidden — book a demo in · Hidden — book a demo out
past 12 months
Source: Dealroom Talent Intelligence.
Alumni founders
Former Epizyme employees who went on to found companies, sorted by Dealroom signal score.
VTVesigen TherapeuticsEst. 2019
Robert MillmanUnited StatesSignal score69
RURulaiEst. 2016YZYi ZhangUnited States
Signal score69
ATAccent TherapeuticsEst. 2017
Robert A. CopelandUnited StatesSignal score68
MMMenlo MicroEst. 2016RSRisa StackUnited States
Signal score65
GOGritstone OncologyEst. 2015
Andrew AllenUnited StatesSignal score65
2 more alumni-founded companies in this previewBook a demo
Global footprint
See Epizyme on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


